Asthma is a heterogeneous disease on a clinical as well as a mechanistic level. A major
molecular mechanism of asthma is considered to be driven by type 2 T-helper cells (Th2) …

Asthma is a chronic inflammatory disease that has reached epidemic proportions worldwide.
It is treatable in the majority of patients, but there is no cure. Moreover, a proportion of …

Administración de omalizumab en pacientes mexicanos con diagnóstico de asma moderada a
grave no atópica Page 1 833 www.medicinainterna.org.mx artículo original Med Int Méx. 2018 …

Résumé Introduction L'omalizumab, un anticorps monoclonal bloquant les
immunoglobulines E, a depuis maintenant dix ans une autorisation de mise sur le marché …

Objective: To assess socio-sanitary expenditure after the addition of omalizumab to standard
treatment in the control of severe asthma and to analyse its effectiveness under standard …

Acute asthma remains one of the most frequent causes of children's access to healthcare.
Asthma exacerbation is an essential defining characteristic of its severity, and respiratory …

Asthma is an important chronic disease affecting a lot of people worldwide. treatment
options for asthma like biological agents are being developed more frequently nowadays …

Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life
experience with omalizumab - PMC Back to Top Skip to main content NIH NLM Logo Access …